ROBERT ANG
CIK 1741283 · PRESIDENT AND CEO · last filed 2025-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.09M
Companies
2
Total Filings
24
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VOR | PRESIDENT AND CEO | 911,318 | $14.36 | $13.09M | $0 | 23 | 2025-05-07 |
| Neon Therapeutics, Inc. (NTGN) Delisted | Chief Business Officer | 279,525 | — | — | $0 | 1 | 2019-03-01 |
Recent Filings · Page 2 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-03 | VOR | Tax (F) | −2,751 | -$4.9K | EDGAR |
| 2024-03-05 | VOR | Tax (F) | −12,657 | -$28.7K | EDGAR |
| 2024-02-08 | VOR | Tax (F) | −2,788 | -$6.5K | EDGAR |
| 2024-01-31 | VOR | Grant (A) | +150,000 | $0 | EDGAR |
| 2023-11-08 | VOR | Tax (F) | −2,361 | -$4.3K | EDGAR |
| 2023-09-06 | VOR | Tax (F) | −12,657 | -$33.8K | EDGAR |
| 2023-08-09 | VOR | Tax (F) | −2,361 | -$6.3K | EDGAR |
| 2023-05-10 | VOR | Tax (F) | −2,361 | -$9.8K | EDGAR |
| 2023-03-02 | VOR | Tax (F) | −12,657 | -$69.7K | EDGAR |
| 2023-02-08 | VOR | Grant (A) | +128,750 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.